“Trevena Has Received A Notice Of Allowance For Its U.S. Patent Application 16/613,152 Titled ‘Compounds For Modulating S1p1 Activity And Methods Of Using The Same (For The Treatment Of Pain)'” – USPTO
https://patentcenter.uspto.gov/applications/16613152/ifw/docs